Juan Poggio
Colon & Rectal Surgery · Philadelphia, PANPI 1487776480
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $40,094 of the $49,473 with a category attached, or 81.0%. Covidien LP accounts for 88.5% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2020 at $29,727 and has fallen 94.4% since, to $1,662 in 2023. Among colon & rectal surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $1301.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$44K
- Intuitive Surgical$5K
- Medtronic$1K
What the payments were for
- Consulting fees$40,09481%
- Travel & lodging$4,4329%
- Food & beverage$4121%
- Education$4,5359%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 22 | $43,790 |
| Intuitive Surgical | 6 | $4,582 |
| Medtronic | 10 | $1,101 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,535
- PERCEPT PC BRAINSENSE$657
- INTERSTIM$110
How this compares
$49,473 in reported general payments places this provider in the 90th percentile of 108 colon & rectal surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 13 | $342 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 17 | $219 |
| Neomycin Sulfate | 19 | $104 |
| Metronidazole | 20 | $56 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Philadelphia
- Joshua BleierPhiladelphia$86K
- Najjia MahmoudPhiladelphia$63K
- Scott GoldsteinPhiladelphia$13K
- Benjamin PhillipsPhiladelphia$4K
- Paul HernandezPhiladelphia$3K
- Bogdan ProtyniakWilkes-Barre$429K
- John MarksWynnewood$155K
- Richard FortunatoPittsburgh$80K
- James McCormickMonroeville$55K
- Christopher BuzasDanville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.